Thus, NAM is decreased at the onset of DCM, and its downstream metabolite NAD+ decreases as DCM progresses, consistent with reduced ATP production in Kdm8 mutant hearts. This evidence concerns the gene KDM8 and familial dilated cardiomyopathy.